# A Medical Chart Review of Patients With X-Linked Myotubular Myopathy (XLMTM)

> **NCT02231697** · — · COMPLETED · sponsor: **Astellas Gene Therapies** · enrollment: 161 (actual)

## Conditions studied

- Males With X-linked Myotubular Myopathy (XLMTM)

## Interventions

- **OTHER:** Non-interventional, retrospective medical chart review

## Key facts

- **NCT ID:** NCT02231697
- **Lead sponsor:** Astellas Gene Therapies
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09
- **Primary completion:** 2019-12
- **Final completion:** 2019-12
- **Target enrollment:** 161 (ACTUAL)
- **Last updated:** 2022-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02231697

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02231697, "A Medical Chart Review of Patients With X-Linked Myotubular Myopathy (XLMTM)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02231697. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
